Internal medical clinical trials of advanced gastric cancer in the past decade
Gastric cancer occupies the fifth and third place in the incidence and mortality rates in our country,respectively,which brings great burden to the patients'life.As the early screening of gastric cancer has not been fully popularized,nearly half of patients with gastric cancer in China have been found to be of advanced stages and have a poor prognosis.In recent years,with the continuous breakthroughs of clinical trials on new anti-tumor drugs,the approvement of new drugs have brought new opportunities for advanced gastric cancer patients.This review summarizes clinical trials in the field of advanced gastric cancer in the past decade,analyzes and expounds the progress of clinical trials in the internal medical treatment of advanced gastric cancer from different perspectives such as targeted therapy,immuno-therapy,anti-angiogenic therapy and new chemotherapy drugs,and forecasts future directions.On this basis,more high-quality clinical trials are expected to be carried out,in order to improve the survival and prognosis of patients with advanced gastric cancer.
国家科技期刊平台
NSTL
万方数据
